ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

JAGX vs OPTH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Jaguar Health Inc. (NASDAQ) VS. Optimi Health Corp. (NASDAQ) • 15-METRIC TALLY: JAGX 2 — OPTH 0
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAGX VS. OPTH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC JAGX OPTH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -0.50% — — TIE /net-margins <GO>
Revenue Growth (YoY) -1.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.6 18.3 +21.33 JAGX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $15.9M $14.9M $1.0M JAGX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR JAGX REV OPTH REV JAGX GROSS % OPTH GROSS % JAGX FCF OPTH FCF
FY 2025 $11.5M — 67.2% — -$23.7M —
FY 2024 $11.7M — 83.3% — -$29.4M —
FY 2023 $9.8M — — — -$33.2M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAGX // BETA —
OPTH // BETA —